Early Stage Venture Solarea Bio Raises Series A of $11200000

About Solarea Bio

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

Website: Learn more on Solarea Bio’s website

Crunchbase: Follow on Crunchbase

Series A – Solarea Bio

Amount Raised11200000 USD
Announced Date2020-10-19
Equity Only FundingYes
Organization LocationCambridge, Massachusetts, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsBold Capital Partners, S2G Ventures
Number of Investors4
Number of Partner Investors2

Written by Startup News

Early Stage Venture Murfy Raises Series A of $9373487

Early Stage Venture Sym Raises Series A of $9000000